🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆
Updated 27 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Oxford

← All UK trials

The most recently updated industry-sponsored clinical trials recruiting across the United Kingdom — searchable by condition, sponsor, phase and city. Refreshed daily from the ClinicalTrials.gov registry.

17
Recruiting now
24
Studies tracked
Oxford
Selected city
Recruiting Phase 3
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
BeOne Medicines · started 2025-09-04
📍 Brighton · Canterbury · Norwich · Oxford · Roundhay
NCT06973187 on ClinicalTrials.gov ↗
Active Phase 2
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)
Primary Sclerosing Cholangitis
Mirum Pharmaceuticals, Inc. · started 2020-12-18
📍 London · Oxford · Belfast · Birmingham · Cambridge
NCT04663308 on ClinicalTrials.gov ↗
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Hypertension, Hypertension, Systolic, Hypertension, Essential
Orchestra BioMed, Inc · started 2023-12-27
📍 London · Oxford · Southhampton
NCT06059638 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
Exelixis · started 2025-07-21
📍 Birmingham · Cardiff · Glasgow · Liverpool · London
NCT06943755 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Major Depressive Disorder (MDD)
Draig Therapeutics Ltd · started 2025-12-16
📍 Chester · Eastbourne · Glasgow · London · Nottingham
NCT07300969 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyneuropathy
Sanofi · started 2024-08-21
📍 London · Inverness · Oxford
NCT06290141 on ClinicalTrials.gov ↗
Active Phase 3
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)
Biliary Tract Neoplasms
AstraZeneca · started 2019-04-16
📍 Bristol · Cambridge · London · Manchester · Oxford
NCT03875235 on ClinicalTrials.gov ↗
Active Phase 1
A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
Solid Tumors
Genentech, Inc. · started 2018-06-06
📍 Oxford
NCT03448042 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Early Alzheimer's Disease
Merck Sharp & Dohme LLC · started 2025-07-16
📍 Aberdeen · Edinburgh · Southampton · London · Oxford
NCT07033494 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
AbbVie · started 2025-04-24
📍 London · Oxford · Sutton · Manchester
NCT06820463 on ClinicalTrials.gov ↗
Active Phase 1
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors
Neoplasms
Tesaro, Inc. · started 2016-03-07
📍 Newcastle upon Tyne · Aberdeen · London · Manchester · Oxford
NCT02715284 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
Unresectable Hepatocellular Carcinoma
Hoffmann-La Roche · started 2021-04-26
📍 Birmingham · Liverpool · London · Manchester · Newcastle upon Tyne
NCT04770896 on ClinicalTrials.gov ↗
Active
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular · started 2021-10-20
📍 Oxford
NCT05198674 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Diabetes Mellitus, Type 1
Eli Lilly and Company · started 2026-01-12
📍 Birmingham · Cambridge · Cardiff · Glasgow · London
NCT07222137 on ClinicalTrials.gov ↗
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc. · started 2025-10-17
📍 London · Oxford
NCT07785180 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Metastatic Breast Cancer
Hoffmann-La Roche · started 2023-09-08
📍 Belfast · Blackpool · Colchester, Essex · Northwood · Nottingham
NCT05894239 on ClinicalTrials.gov ↗
Recruiting Phase 2
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Type 1 Diabetes
SAb Biotherapeutics, Inc. · started 2025-11-25
📍 Cambridge · Cardiff · Edinburgh · Liverpool · London
NCT07187531 on ClinicalTrials.gov ↗
Recruiting Phase 3
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Healthy
Pfizer · started 2025-08-25
📍 Bristol · London · Truro · Southampton · Manchester
NCT07160244 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Merck Sharp & Dohme LLC · started 2023-12-18
📍 Cambridge · Derby · Torquay · Northwood · Truro
NCT06136650 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
Eli Lilly and Company · started 2021-05-26
📍 London · Oxford · Sheffield
NCT04844606 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
Crohn's Disease
Takeda · started 2026-08-13
📍 Oxford
NCT07403968 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis
Eli Lilly and Company · started 2019-04-05
📍 Bristol · Liverpool · London · Oxford · Sheffield
NCT03773965 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
Pfizer · started 2021-10-04
📍 Bournemouth · Oxford · Cardiff · Bristol · Canterbury
NCT05020236 on ClinicalTrials.gov ↗
Active
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
Colitis, Ulcerative
Pfizer · started 2024-05-08
📍 Glasgow · Nottingham · Oxford · Edinburgh · Crumpsall
NCT06294925 on ClinicalTrials.gov ↗
No trials match your search.

Browse by city

London · 115 Manchester · 41 Cambridge · 34 Birmingham · 30 Glasgow · 25 Oxford · 24 Edinburgh · 20 Sheffield · 20 Leicester · 17 Newcastle upon Tyne · 15 Bristol · 15 Liverpool · 14 Leeds · 13 Southampton · 13 Cardiff · 12 Sutton · 11

Browse by condition

Chronic Lymphocytic Leukemia · 4 Colitis, Ulcerative · 3 Non-small Cell Lung Cancer · 3 Carcinoma, Non-Small-Cell Lung · 3 Breast Cancer · 3 Crohn's Disease · 3 Rheumatoid Arthritis · 2 Hypertension · 2 Alzheimer Disease · 2 Age-Related Macular Degeneration · 2 Prostatic Neoplasms · 2 Type 1 Diabetes · 2 Major Depressive Disorder (MDD) · 2 Idiopathic Pulmonary Fibrosis · 2 Chronic Inflammatory Demyelinatin… · 2 Amyotrophic Lateral Sclerosis · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the UK Tracker. Available at: https://priyalifescience.com/clinical-trials-uk/city/oxford (Accessed: 27 August 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one UK site, most recently updated first, refreshed daily. This is a curated slice of the registry, not every UK trial; UK studies may also be registered on ISRCTN. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our UK Pharma Salary Guide, or see our Ireland, EU and USA trackers.